NCT01773772View on ClinicalTrials.gov

Progesterone Suppression of Nocturnal LH Increases in Pubertal Girls

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 8, 2005

Primary Completion Date

June 8, 2009

Study Completion Date

June 8, 2009

Conditions
Female Puberty
Interventions
DRUG

Progesterone

Subjects will take 25-50 mg oral micronized progesterone at 1600 h and again at 2000 h. Progesterone dosing will be based on weight, with 25 mg administered to girls \< 42kg and 50 mg given to those or = to 42 kg.

DRUG

Placebo

Subjects will take oral placebo suspension at 1600 h and again at 2000 h.

Trial Locations (1)

22908

University of Virginia Center for Research in Reproduction, Charlottesville

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Virginia

OTHER

NCT01773772 - Progesterone Suppression of Nocturnal LH Increases in Pubertal Girls | Biotech Hunter | Biotech Hunter